Gapping up
In reaction to strong earnings/guidance: EBIO +32%, OPXA +15%, GBSN +14.6%, PGN +12.9%, CRNT +12.5%, SEDG +10.4%, RNDY +9.1%, CLCD +6.5%, SVT +6.1%, BGG +5.1%, NWSA +4.8%, SVA +4.5%, KINS +4.3%, DARA +3.7%, CSAL +3.7%, CSCO +3.4%, CSCO +3.4%, TDOC +2.9%, LXFT +2.5%, CPG +1.4%, DDS +1.2%, JUNO +1%
M&A news: PLNR +33.3% (to be acquired by Leyard for $6.58 per share), PRGO +0.9% (Mylan (MYL) lowers the acceptance condition for its offer to acquire Perrigo, from not less than 80% of shares, to greater than 50% )
Other news: OHGI +92% (agreement to be the exclusive supplier of Voice over IP services to KeyIdea Information Technology), IMUC +43.2% (reaches an agreement with the FDA on a Special Protocol Assessment for its ICT-107 Phase 3 registrational trial), GALT +32.4% (receives U.S. Patent notice of allowance for use of Pectin compounds to reduce fibrosis in multiple diseases), ALIM +4.3% (signs an exclusive five-year agreement with Societa Industria Farmaceutica Italiana S.p.A., for the distribution of Iluvien in Italy, San Marino and the Vatican City), SUNE +4.2% (SunEdison signs a definitive agreement with Dominion (D) to establish a JV Four Brothers, a 420 megawatt (MW) DC, or 320 megawatt AC, solar project in Utah), S +4.1% (SoftBank Group (SFTBY) discloses it acquired additional shares of Sprint), BDSI +4% (announces US FDA approval of an SNDA for a new formulation of Onsolis CII to manage breakthrough pain in opoid intolerant cancer patients), CMCM +3.3% (China mkts rebound overnight), JD +2.5% (rebounding after recent declines), ITEK +2.5% (prices offering of 5,400,000 shares of its common stock at $12.75 per share), FGEN +2.4% (announced that Nephrology Dialysis Transplantation has published 'encouraging' Phase 2a safety and efficacy data for roxadustat for the treatment of anemia associated with chronic kidney disease), FIT +2.3% (cont volatility), NVAX +2.2% (favorable commentary on Wednesday's Mad Money ), TSLA +1.9% (announces a $500 mln common stock offering; CEO Elon Musk intends to purchase $20 mln of the offering), GSAT +1.6% (NASA selecte Globalstar and ADS-B technologies' ALAS aviation tracking solution), MN +1.1% (reports July, 2015 prelim AUM of $41.7 billion, down from $43.1 billion in prior month)
Analyst comments: GWPH +4% (initiated with a Overweight at Morgan Stanley), BBEP +3% (upgraded to Neutral from Sell at UBS), GPRO +3% (initiated with an Outperform at Cowen), YHOO +1.5% (upgraded to Outperform from Mkt Perform at Bernstein ), QLIK +1.3% (upgraded to Buy from Hold at Deutsche Bank), RAD +1.3% (initiated with a Buy at BofA/Merrill), MNST +1% (upgraded to Overweight from Equal-Weight at Morgan Stanley), MSFT +1% (upgraded to Buy from Hold at Stifel), EZCH +0.9% (upgraded to Buy from Hold at Brean Capital)